In this study, we introduced a new simple effective technique for the treatment of diabetic retinopathy by the treatment of the periphery of the retina by transscleral micropulse diode laser (Taha Technique). Macular edema was improved and vitreous hemorrhage was disappeared in most of the cases.
Introduction/Background:
Micropulse Diode Laser Photocoagulation (MD) is designed to target The Retinal Pigment Epithelium (RPE) melanocytes while avoiding photoreceptors damage. The term "subthreshold" refers to photocoagulation that does not produce visible intraretinal damage or visible scarring either during or after treatment. It is well known that burns cannot be detected by clinical examination or by Intravenous Fluorescein Angiography (IVFA) and Fundus Autofluorescene (FAF) 1, 2 .
Photocoagulation of all layers of retina is not needed to get the therapeutic 
Results:
Patients follow up ranged from one month to one year. Visual acuity were improved in 68% of treated eyes in group 1 , and in 84 % of eyes in group 2.
3 Statistically significant reduction of macular edema was in 70 % of eyes in group 1.
Total disappearance of vitreous hemorrhage and reduction of diabetic retinopathy was observed in 80 % of eyes in group 2. No adverse laser events occurred, no laser lesions were detectable clinically or angiographically after treatment.
Group (1):
Figure (1): Case number 1 with diabetic macular edema which shows marked
